resources

Sai Life Sciences Ltd.

NSE: SAILIFE

BSE: 544306

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

1,647.10+67.5 (+4.27%)

8 Sep, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Sai Life Sciences Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2024	2025	2026
Annual Reports	—	FY 2025	FY 2026
Quarterly Results	Dec	Mar Jun Sept Dec	Mar Jun
Conference Calls	—	12Feb 21May 18Aug 14Nov	13Feb 21May 12Aug
Presentations	—	7Feb 25Feb 14May 8Aug 7Nov	6Feb 15May 7Aug

Corporate Announcements and Regulatory Filings

Sai Life Sciences Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Analyst / Investor Meet4 Sept 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investors Conference - 18th September 2026
Analyst / Investor Meet4 Sept 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investors Conference - 14th September 2026
Allotment of ESOP / ESPS1 Sept 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of 80,600 Equity shares having Face Value ?1/- each as per Company''s ESOP Plans
Newspaper Publication26 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication relating to 27th AGM (Post-dispatch Advt.)
General25 Aug 2026
Weblink Letter To Shareholders - As Per Regulation 36(1)(B) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please refer the attachment
Business Responsibility and Sustainability Reporting (BRSR)25 Aug 2026
Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report (BRSR) and ESG Databook of Sai Life Sciences Limited for the FY 2025-26
Reg. 34 (1) Annual Report25 Aug 2026
Reg. 34 (1) Annual Report.
Integrated Annual Report of Sai Life Sciences Limited for the FY 2025-26
AGM25 Aug 2026
Notice Of 27Th Annual General Meeting (AGM) Of The Company
Notice of 27th Annual General Meeting (AGM) of the Company
Newspaper Publication24 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication relating to 27th AGM (Pre-dispatch Advt.)
AGM24 Aug 2026
Information Relating To 27Th Annual General Meeting (AGM) And Cut-Off Date For E-Voting.
Information relating to 27th Annual General Meeting (AGM) and Cut-off date for e-voting.
Newspaper Publication8 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication for Un-audited Financial Results of the Company for the quarter ended on 30 June 2026
Monitoring Agency Report7 Aug 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Monitoring Agency Report for the Quarter ended on 30 June 2026
Analyst / Investor Meet7 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Recording of Earnings Call for the Unaudited Financial Results of the Company for the quarter ended on 30 June 2026.
Press Release / Media Release6 Aug 2026
Press Release For The Unaudited Financial Results For The Quarter Ended On June 30, 2026
Press Release for the Unaudited financial results for the quarter ended 30 June 2026
Outcome of Board Meeting6 Aug 2026
Board Meeting Outcome for Considered And Approved The Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended On 30 June 2026
Board Meeting Outcome for Approval of Unaudited Financial Results (Standalone and Consolidated) For the Quarter Ended On 30 June 2026
Analyst / Investor Meet4 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst/Investor Meet on 13 August 2026 and 14 August 2026 at Singapore
Analyst / Investor Meet30 Jul 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Earnings Conference call Invite to discuss Un-audited Financial Results of the Company for the Quarter ended 30 June 2026.
Allotment of Equity Shares10 Jul 2026
Announcement under Regulation 30 (LODR)-Allotment
Allotment of 8,900 Equity Shares under ESOP 2008 Scheme of the Company
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please refer to enclosed Intimation
Board Meeting1 Jul 2026
Board Meeting Intimation for Notice Of Board Meeting
Sai Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve Un-audited Financial Results ....

Frequently Asked Questions

Where can I download the annual report of Sai Life Sciences Ltd.?

Annual reports of Sai Life Sciences Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Sai Life Sciences Ltd.?

Quarterly earnings results and presentations of Sai Life Sciences Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Sai Life Sciences Ltd. publish earnings call transcripts?

Earnings call transcripts of Sai Life Sciences Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Sai Life Sciences Ltd.?

Investor presentations and annual day presentations of Sai Life Sciences Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Sai Life Sciences Ltd.?

Corporate announcements and regulatory filings of Sai Life Sciences Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Sai Life Sciences Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Sai Life Sciences Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Sai Life Sciences Ltd.?

The ISIN (International Securities Identification Number) of Sai Life Sciences Ltd. is INE570L01029. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Sai Life Sciences Ltd. listed?

Sai Life Sciences Ltd. is listed on NSE and BSE. The NSE symbol is SAILIFE and the BSE code is -.

Where can I find the shareholding pattern of Sai Life Sciences Ltd.?

The quarterly shareholding pattern of Sai Life Sciences Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Sai Life Sciences Ltd. on Sharpely?

Share price data for Sai Life Sciences Ltd. is updated as of 8 Sep 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.